Chemoprevention of lung carcinogenesis using green tea: phase IIb randomized, double-blinded, placebo controlled trial of green tea and polyphenon E in former smokers with chronic obstructive lung disease (COPD).

Trial Profile

Chemoprevention of lung carcinogenesis using green tea: phase IIb randomized, double-blinded, placebo controlled trial of green tea and polyphenon E in former smokers with chronic obstructive lung disease (COPD).

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2013

At a glance

  • Drugs Polyphenon E (Primary) ; Green tea
  • Indications Lung cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 27 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Jun 2008 The expected completion date for this trial is now 1 Feb 2009, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top